Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination

Veterinary Microbiology

Volumn 172, Issue 1-2, 2014, Pages 44-50

  Wilson, William C ^a   Bawa, Bhupinder ^b   Drolet, Barbara S ^a   Lehiy, Chris ^a   Faburay, Bonto ^b   Jasperson, Dane C ^a   Reister, Lindsey ^a   Gaudreault, Natasha N ^a   Carlson, Jolene ^b   Ma, Wenjun ^b   Morozov, Igor ^b   McVey, D Scott ^a   Richt, Jürgen A ^b  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cattle; Rift Valley fever virus; Sheep; Vaccine

Indexed keywords

RIFT VALLEY FEVER VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; AUTOPSY; CALF (BOVINE); CONTROLLED STUDY; DRUG SAFETY; FEVER; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFANT; LAMB; LIVER NECROSIS; NONHUMAN; RIFT VALLEY FEVER; TARGET ORGANISM; TISSUE DEGENERATION; VACCINATION; VIRUS IMMUNITY; VIRUS STRAIN;

ANIMALIA; BOS; OVIS ARIES; RIFT VALLEY FEVER VIRUS;

CATTLE; RIFT VALLEY FEVER VIRUS; SHEEP; VACCINE;

AGE FACTORS; ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; HOST SPECIFICITY; HUMANS; IMMUNITY, ACTIVE; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SHEEP; SHEEP DISEASES; SHEEP, DOMESTIC; VACCINATION; VACCINES, ATTENUATED; VIRAL LOAD; VIRAL VACCINES;

EID: 84903457739     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.04.007     Document Type: Article

References (36)

1. Abdo-Salem S., Tran A., Grosbois V., Gerbier G., Al-Qadasi M., Saeed K., Etter E., Thiry E., Roger F., Chevalier V. Can environmental and socioeconomic factors explain the recent emergence of Rift Valley Fever in Yemen, 2000-2001?. Vector Borne Zoonotic Dis. 2011, 11:773-779.
2. Archer B.N., Weyer J., Paweska J., Nkosi D., Leman P., Tint K.S., Blumberg L. Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008. S. Afr. Med. J. 2011, 101:263-266.
3. Bando B.M. Isolation of bluetongue and epizootic hemorrhagic disease viruses in cell culture. Proc. Amer. Assn. Vet. Lab. 1975, 18:163-174.
4. Bird B.H., Nichol S.T. Breaking the chain: Rift Valley fever virus control via livestock vaccination. Curr. Opin. Virol. 2012, 2:315-323.
5. Bird B.H., Khristova M.L., Rollin P.E., Ksiazek T.G., Nichol S.T. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J. Virol. 2007, 81:2805-2816.
6. Bird B.H., Ksiazek T.G., Nichol S.T., Maclachlan N.J. Rift Valley fever virus. J. Am. Vet. Med. Assoc. 2009, 234:883-893.
7. Caplen H., Peters C.J., Bishop D.H. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol. 1985, 66(Pt 10):2271-2277.
8. Drolet B.S., Weingartl H.M., Jiang J., Neufeld J., Marszal P., Lindsay R., Miller M.M., Czub M., Wilson W.C. Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories. J. Virol. Methods 2012, 179:373-382.
9. Drosten C., Gottig S., Schilling S., Asper M., Panning M., Schmitz H., Gunther S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 2002, 40:2323-2330.
10. El Mamy A.B., Baba M.O., Barry Y., Isselmou K., Dia M.L., El Kory M.O., Diop M., Lo M.M., Thiongane Y., Bengoumi M., Puech L., Plee L., Claes F., de La Rocque S., Doumbia B. Unexpected Rift Valley fever outbreak, northern Mauritania. Emerg. Infect. Dis. 2011, 17:1894-1896.
11. Elliott R.M., Schmaljohn C.S. Bunyaviridae. Fields Virology 2013, 1244-1278. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
12. Gerdes G.H. Rift Valley fever. The veterinary clinics of North America. Food Anim. Pract. 2002, 18:549-555.
13. Hartley D.M., Rinderknecht J.L., Nipp T.L., Clarke N.P., Snowder G.D. Potential effects of Rift Valley fever in the United States. Emerg. Infect. Dis. 2011, 17:e1.
14. Hill R.E. Issuance of a Conditional License for Rift Valley Fever Vaccine, Modified Live Virus 2012, USDA, A, Center for Veterinary Biologics.
15. Hunter P., Erasmus B.J., Vorster J.H. Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. Onderstepoort J. Vet. Res. 2002, 69:95-98.
16. Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res. 2012, 95:293-310.
17. Imam I.Z., Darwish M.A., El-Karamany R. An epidemic of Rift Valley fever in Egypt. 1. Diagnosis of Rift Valley fever in man. Bull. World Health Organ. 1979, 57:437-439.
18. Indran S.V., Ikegami T. Novel approaches to develop Rift Valley fever vaccines. Front. Cel. Infect. Microbiol. 2012, 2:131.
19. Jansen van Vuren P., Potgieter A.C., Paweska J.T., van Dijk A.A. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J. Virol. Methods 2007, 140:106-114.
20. Jeanmaire E.M., Rabenarivahiny R., Biarmann M., Rabibisoa L., Ravaomanana F., Randriamparany T., Andriamandimby S.F., Diaw C.S., Fenozara P., de La Rocque S., Reynes J.M. Prevalence of Rift Valley fever infection in ruminants in Madagascar after the 2008 outbreak. Vector Borne Zoonotic Dis. 2011, 11:395-402.
21. Kortekaas J., Antonis A.F., Kant J., Vloet R.P., Vogel A., Oreshkova N., de Boer S.M., Bosch B.J., Moormann R.J. Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine 2012, 30:3423-3429.
22. Ksiazek T.G., Jouan A., Meegan J.M., Le Guenno B., Wilson M.L., Peters C.J., Digoutte J.P., Guillaud M., Merzoug N.O., Touray E.M. Rift Valley fever among domestic animals in the recent West African outbreak. Res. Virol. 1989, 140:67-77.
23. Madani T.A., Al-Mazrou Y.Y., Al-Jeffri M.H., Mishkhas A.A., Al-Rabeah A.M., Turkistani A.M., Al-Sayed M.O., Abodahish A.A., Khan A.S., Ksiazek T.G., Shobokshi O. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin. Infect. Dis. 2003, 37:1084-1092.
24. Morrill J.C., Peters C.J. Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 2003, 21:2994-3002.
25. Morrill J.C., Peters C.J. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus. J. Infect. Dis. 2011, 204:229-236.
26. Morrill J.C., Jennings G.B., Caplen H., Turell M.J., Johnson A.J., Peters C.J. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am. J. Vet. Res. 1987, 48:1042-1047.
27. Morrill J.C., Carpenter L., Taylor D., Ramsburg H.H., Quance J., Peters C.J. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 1991, 9:35-41.
28. Morrill J.C., Mebus C.A., Peters C.J. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am. J. Vet. Res. 1997, 58:1104-1109.
29. Morrill J.C., Mebus C.A., Peters C.J. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am. J. Vet. Res. 1997, 58:1110-1114.
30. Nguku P.M., Sharif S.K., Mutonga D., Amwayi S., Omolo J., Mohammed O., Farnon E.C., Gould L.H., Lederman E., Rao C., Sang R., Schnabel D., Feikin D.R., Hightower A., Njenga M.K., Breiman R.F. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007. Am. J. Trop. Med. Hyg. 2010, 83:5-13.
31. Pepin M., Bouloy M., Bird B.H., Kemp A., Paweska J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 2010, 41:61.
32. Schroeder M.E., Bounpheng M.A., Rodgers S., Baker R.J., Black W., Naikare H., Velayudhan B., Sneed L., Szonyi B., Clavijo A. Development and performance evaluation of calf diarrhoea pathogen nucleic acid purification and detection workflow. J. Vet. Diagn. Invest. 2012, 24:945-953.
33. Smith D.R., Bird B.H., Lewis B., Johnston S.C., McCarthy S., Keeney A., Botto M., Donnelly G., Shamblin J., Albarino C.G., Nichol S.T., Hensley L.E. Development of a novel nonhuman primate model for Rift Valley fever. J. Virol. 2012, 86:2109-2120.
34. Turell M.J., Wilson W.C., Bennett K.E. Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus. J. Med. Entomol. 2010, 47:884-889.
35. Wilson W.C., Romito M., Jasperson D.C., Weingartl H., Binepal Y.S., Maluleke M.R., Wallace D.B., Jansen van Vuren P., Paweska J.T. Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments. J. Virol. Methods 2013, 193:426-431.
36. Woods C.W., Karpati A.M., Grein T., McCarthy N., Gaturuku P., Muchiri E., Dunster L., Henderson A., Khan A.S., Swanepoel R., Bonmarin I., Martin L., Mann P., Smoak B.L., Ryan M., Ksiazek T.G., Arthur R.R., Ndikuyeze A., Agata N.N., Peters C.J. An outbreak of Rift Valley fever in Northeastern Kenya 1997-1998. Emerg. Infect. Dis. 2002, 8:138-144.